Nifty
Sensex
:
:
24213.30
79476.63
217.95 (0.91%)
694.39 (0.88%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524280 | NSE: KOPRAN

252.25
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  252.45
  •  256.95
  •  250.65
  •  252.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  428547
  •  1090.66
  •  369.70
  •  198.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,495.97
  • 25.24
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,581.00
  • 0.97%
  • 2.98

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.49%
  • 6.93%
  • 40.75%
  • FII
  • DII
  • Others
  • 1.31%
  • 0.00%
  • 6.52%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.55
  • 11.32
  • 8.78

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.99
  • 9.75
  • -3.14

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.39
  • 19.38
  • -5.83

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.15
  • 16.43
  • 23.89

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.15
  • 2.35
  • 2.54

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.05
  • 11.62
  • 14.57

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
139.44
117.00
19.18%
186.08
148.88
24.99%
158.92
158.00
0.58%
152.59
116.97
30.45%
Expenses
121.27
110.69
9.56%
164.39
136.72
20.24%
135.34
145.68
-7.10%
129.76
106.82
21.48%
EBITDA
18.16
6.31
187.80%
21.69
12.16
78.37%
23.58
12.32
91.40%
22.83
10.14
125.15%
EBIDTM
13.03%
5.39%
11.66%
8.17%
14.84%
7.80%
14.96%
-4.88%
Other Income
2.63
2.39
10.04%
9.67
3.78
155.82%
2.43
2.22
9.46%
0.13
0.44
-70.45%
Interest
2.18
1.83
19.13%
2.59
1.78
45.51%
2.24
2.24
0.00%
1.94
1.28
51.56%
Depreciation
3.87
3.26
18.71%
3.59
3.24
10.80%
3.27
3.16
3.48%
2.77
3.25
-14.77%
PBT
14.73
3.61
308.03%
25.18
10.92
130.59%
20.51
9.14
124.40%
18.25
6.05
201.65%
Tax
3.64
0.84
333.33%
6.56
2.88
127.78%
4.71
2.19
115.07%
4.48
1.39
222.30%
PAT
11.09
2.77
300.36%
18.62
8.04
131.59%
15.79
6.95
127.19%
13.77
4.65
196.13%
PATM
7.96%
2.37%
10.01%
5.40%
9.94%
4.40%
9.02%
-10.84%
EPS
2.30
0.58
296.55%
3.86
1.67
131.14%
3.28
1.44
127.78%
2.86
-0.96
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
637.03
614.59
550.99
477.52
491.81
359.50
357.90
313.32
309.72
296.32
325.73
Net Sales Growth
17.78%
11.54%
15.39%
-2.91%
36.80%
0.45%
14.23%
1.16%
4.52%
-9.03%
 
Cost Of Goods Sold
407.54
374.40
334.49
248.55
283.34
192.78
190.88
171.87
164.89
166.92
194.27
Gross Profit
229.49
240.19
216.50
228.97
208.47
166.72
167.02
141.44
144.82
129.39
131.46
GP Margin
36.02%
39.08%
39.29%
47.95%
42.39%
46.38%
46.67%
45.14%
46.76%
43.67%
40.36%
Total Expenditure
550.76
540.23
499.19
390.28
410.20
312.80
312.47
284.27
273.60
266.09
294.29
Power & Fuel Cost
-
24.52
23.16
19.27
16.65
18.08
17.10
14.90
13.71
14.10
12.93
% Of Sales
-
3.99%
4.20%
4.04%
3.39%
5.03%
4.78%
4.76%
4.43%
4.76%
3.97%
Employee Cost
-
52.28
49.95
43.27
37.16
36.85
37.11
32.24
31.37
28.02
28.83
% Of Sales
-
8.51%
9.07%
9.06%
7.56%
10.25%
10.37%
10.29%
10.13%
9.46%
8.85%
Manufacturing Exp.
-
45.34
42.67
38.78
33.89
30.06
32.41
31.35
31.84
27.80
25.56
% Of Sales
-
7.38%
7.74%
8.12%
6.89%
8.36%
9.06%
10.01%
10.28%
9.38%
7.85%
General & Admin Exp.
-
29.56
27.86
28.23
26.35
20.99
18.92
19.20
16.93
15.68
15.38
% Of Sales
-
4.81%
5.06%
5.91%
5.36%
5.84%
5.29%
6.13%
5.47%
5.29%
4.72%
Selling & Distn. Exp.
-
9.40
9.31
8.54
8.42
9.36
9.18
9.56
8.46
9.35
8.16
% Of Sales
-
1.53%
1.69%
1.79%
1.71%
2.60%
2.56%
3.05%
2.73%
3.16%
2.51%
Miscellaneous Exp.
-
4.72
11.77
3.64
4.40
4.69
6.86
5.15
6.39
4.22
8.16
% Of Sales
-
0.77%
2.14%
0.76%
0.89%
1.30%
1.92%
1.64%
2.06%
1.42%
2.82%
EBITDA
86.26
74.36
51.80
87.24
81.61
46.70
45.43
29.05
36.12
30.23
31.44
EBITDA Margin
13.54%
12.10%
9.40%
18.27%
16.59%
12.99%
12.69%
9.27%
11.66%
10.20%
9.65%
Other Income
14.86
14.67
3.06
10.76
18.15
0.63
3.96
10.94
10.66
2.37
6.54
Interest
8.95
8.59
6.08
5.12
6.24
8.91
8.99
8.60
13.70
12.56
12.97
Depreciation
13.50
12.89
12.71
11.10
10.19
9.58
8.74
8.51
8.33
8.12
9.64
PBT
78.67
67.54
36.07
81.78
83.34
28.84
31.66
22.89
24.76
11.91
15.36
Tax
19.39
16.59
8.83
20.75
21.73
7.26
7.64
2.40
4.85
0.00
0.00
Tax Rate
24.65%
24.56%
24.48%
25.37%
26.07%
25.66%
24.13%
10.48%
19.59%
0.00%
0.00%
PAT
59.27
50.96
27.23
61.03
61.61
21.02
24.02
20.49
19.91
10.72
-39.12
PAT before Minority Interest
59.27
50.96
27.23
61.03
61.61
21.02
24.02
20.49
19.91
10.72
-39.12
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
9.30%
8.29%
4.94%
12.78%
12.53%
5.85%
6.71%
6.54%
6.43%
3.62%
-12.01%
PAT Growth
164.48%
87.15%
-55.38%
-0.94%
193.10%
-12.49%
17.23%
2.91%
85.73%
-
 
EPS
12.30
10.57
5.65
12.66
12.78
4.36
4.98
4.25
4.13
2.22
-8.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
491.25
439.25
426.17
245.03
189.68
168.48
144.71
124.67
108.72
98.52
Share Capital
48.21
48.21
48.21
43.25
43.25
43.25
43.25
43.25
51.83
49.68
Total Reserves
442.00
391.04
377.96
201.78
146.43
125.23
101.46
81.42
56.89
34.65
Non-Current Liabilities
33.47
33.48
33.13
33.67
40.48
46.17
31.45
32.17
33.00
18.31
Secured Loans
0.45
0.65
0.15
0.33
0.15
0.28
0.44
0.33
0.33
0.63
Unsecured Loans
16.16
17.24
18.62
20.88
31.68
40.84
29.48
32.17
28.36
13.38
Long Term Provisions
9.00
8.51
8.09
7.47
7.20
6.42
5.14
4.59
4.31
4.31
Current Liabilities
218.53
176.97
151.59
160.68
140.05
134.71
135.53
136.49
122.08
158.21
Trade Payables
113.09
87.38
62.30
85.91
54.74
51.16
60.67
47.13
57.04
69.22
Other Current Liabilities
22.80
32.85
31.40
28.85
38.17
35.24
21.30
29.91
26.64
36.70
Short Term Borrowings
81.02
55.51
53.71
43.08
46.23
45.44
52.11
56.09
38.00
51.38
Short Term Provisions
1.63
1.23
4.17
2.84
0.91
2.87
1.45
3.36
0.41
0.90
Total Liabilities
743.25
649.70
610.89
439.38
370.21
349.36
311.69
293.33
263.80
275.04
Net Block
181.71
164.99
150.69
112.19
111.15
112.62
104.44
104.47
100.88
101.56
Gross Block
263.47
233.83
206.81
157.31
146.31
138.14
121.27
112.80
314.06
306.73
Accumulated Depreciation
81.76
68.84
56.12
45.12
35.16
25.52
16.84
8.33
213.18
205.18
Non Current Assets
289.22
250.63
196.01
162.43
147.61
141.79
118.20
113.62
109.78
105.06
Capital Work in Progress
96.59
69.58
35.55
42.89
30.24
24.29
9.93
6.29
3.13
1.23
Non Current Investment
0.06
0.06
0.06
0.05
0.02
0.02
0.05
0.05
0.11
0.11
Long Term Loans & Adv.
9.11
14.33
8.19
6.09
4.90
3.54
2.47
2.30
5.61
2.09
Other Non Current Assets
1.75
1.67
1.53
1.22
1.29
1.32
1.31
0.50
0.03
0.06
Current Assets
454.03
399.07
414.87
276.95
222.60
207.57
193.50
179.72
154.01
169.98
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
138.49
130.61
149.94
100.00
88.50
73.45
71.01
60.56
58.84
45.30
Sundry Debtors
212.33
162.56
127.36
120.08
92.81
86.64
64.77
73.11
56.89
81.17
Cash & Bank
14.20
12.58
57.13
6.90
4.75
3.96
6.18
6.88
4.71
3.73
Other Current Assets
89.02
5.77
4.89
5.83
36.55
43.52
51.54
39.16
33.58
39.78
Short Term Loans & Adv.
43.34
87.55
75.55
44.14
34.26
37.98
47.57
37.33
32.65
38.23
Net Current Assets
235.50
222.10
263.29
116.26
82.55
72.85
57.96
43.23
31.93
11.78
Total Assets
743.25
649.70
610.88
439.38
370.21
349.36
311.70
293.34
263.79
275.04

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
43.26
34.02
-33.48
59.95
31.00
25.41
25.77
15.87
28.63
46.30
PBT
67.54
36.07
81.78
83.34
28.84
31.66
22.89
24.76
10.72
-39.12
Adjustment
20.96
16.29
13.82
16.44
21.63
13.35
13.52
25.15
19.63
76.87
Changes in Working Capital
-30.91
-5.55
-110.81
-23.79
-11.77
-15.72
-7.56
-33.13
-1.71
8.58
Cash after chg. in Working capital
57.59
46.81
-15.21
75.98
38.70
29.30
28.84
16.78
28.64
46.32
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.33
-12.79
-18.27
-16.03
-7.15
-3.88
-3.07
-0.91
-0.01
-0.02
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
-0.55
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-43.55
-12.65
-84.42
-25.28
-12.52
-24.86
-10.96
-17.96
-9.07
-9.62
Net Fixed Assets
-10.46
-5.97
-3.31
-4.35
-4.86
-5.66
-5.43
35.65
-4.54
195.52
Net Investments
-1.20
-0.64
-100.64
-0.65
-0.62
-0.60
-0.32
-0.53
-110.00
-39.20
Others
-31.89
-6.04
19.53
-20.28
-7.04
-18.60
-5.21
-53.08
105.47
-165.94
Cash from Financing Activity
0.99
-19.84
122.82
-34.57
-18.06
-0.58
-15.02
1.97
-19.34
-36.90
Net Cash Inflow / Outflow
0.69
1.53
4.93
0.10
0.42
-0.03
-0.21
-0.12
0.22
-0.22
Opening Cash & Equivalents
7.40
5.87
0.94
0.83
0.41
0.44
0.66
0.78
0.56
0.79
Closing Cash & Equivalent
8.09
7.40
5.87
0.94
0.83
0.41
0.44
0.66
0.78
0.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
101.68
91.11
88.40
56.65
43.86
38.95
33.46
28.83
23.15
18.43
ROA
7.32%
4.32%
11.62%
15.22%
5.84%
7.27%
6.77%
7.15%
3.98%
-13.63%
ROE
10.96%
6.29%
18.19%
28.34%
11.74%
15.34%
15.21%
17.71%
12.19%
-43.06%
ROCE
13.78%
8.30%
21.40%
30.40%
13.69%
16.30%
13.88%
19.24%
13.09%
-12.48%
Fixed Asset Turnover
2.47
2.53
2.66
3.30
2.54
2.76
2.69
1.49
0.98
1.11
Receivable days
111.32
94.82
93.20
77.53
90.59
77.21
79.96
74.44
82.54
74.79
Inventory Days
79.90
91.76
94.14
68.65
81.75
73.66
76.30
68.37
62.26
53.60
Payable days
97.72
81.67
108.83
90.60
60.78
68.76
72.54
73.61
89.54
68.97
Cash Conversion Cycle
93.50
104.91
78.51
55.58
111.55
82.11
83.72
69.21
55.25
59.43
Total Debt/Equity
0.20
0.17
0.17
0.27
0.47
0.58
0.61
0.76
0.65
0.92
Interest Cover
8.86
6.93
16.98
14.36
4.17
4.52
3.66
2.81
1.85
-2.02

News Update:


  • Kopran - Quarterly Results
    8th Aug 2024, 12:35 PM

    Read More
  • Kopran’s arm gets environmental clearance to manufacture synthetic organic chemicals
    31st Jul 2024, 14:56 PM

    The company will now obtain CTE and CCA from Gujarat Pollution Control Board for additional capacities approval under the Environmental Clearance received

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.